
The Saliva Glucose
Biosensor
Our technology has the potential to replace the need for finger-prick blood glucose testing.
The Saliva Glucose Biosensor is a non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva, not blood. Our innovative technology could free people living with diabetes from having to use painful and invasive blood monitoring devices to manage their condition, providing a better quality of life.
We intend to demonstrate that the Saliva Glucose Biosensor can be used as a point of care self-test, indicated for the management of diabetes, non-adjunctive to blood glucose testing for diabetes treatment decisions.
* For illustrative purposes only and has yet to receive regulatory approval in any jurisdiction.
Step One
Place the Saliva Glucose Biosensor in contact with saliva.
Step Two
A digital app displays the glucose measurement, flagging any data that needs attention.
Step Three
The app provides real-time comparisons with historical data and sends data to an electronic medical record or caregiver.
Predictive Analytics
The Saliva Glucose Biosensor System could allow a patient to achieve better glucose control through a practical understanding of lifestyle factors that affect glucose levels, helping prevent or delay diabetes complications and ultimately personalizing diabetes management.
At the patient’s or authorized carer’s requirement, data could be disseminated to a remote caregiver, a consultation service, or any other individual with whom the patient chooses to share their glucose level measurements.
Historic glucose
level comparison
Two-way
data flow
Improved Glucose
Management
Better Health
Outcomes
THE Biosensor Platform
A precise, accurate solution for measuring glucose in saliva.
The Saliva Glucose Biosensor is being developed from the Biosensor Platform, a small, printable organic strip designed to put the power of accurate, timely diagnosis in the hands of patients and their primary health practitioners.
Because glucose concentrations are considerably lower in saliva than in capillary blood, detection sensitivity is of critical importance.
The underlying Biosensor technology of the Saliva Glucose Biosensor shows a linear glucose response at concentrations 100 times more sensitive than commercial blood glucose sensors.
Future Outlook
The Patient
- Pain-free, non-invasive and easy-to-use
- Receives alerts and reminders
- Discrete and affordable
The Doctor
- Remote monitoring of patients and management of diabetes
- Providing patient care beyond the clinic in real-time
Healthcare System
- Reduces the cost of managing diabetes as it reduces hospitalization from comorbidities
- Greater collection of patient data opens significant opportunities to improve disease management
Families
- Get updates in real-time, offering peace of mind
- Parallel monitoring
DIABETES
A Global Epidemic
people with diabetes worldwide by 2045
currently live with diabetes
adults are at increased risk of developing type 2 diabetes
Source: IDF Diabetes Atlas